Home Subintro

Subintro

In operation
-
Antiviral Therapy Developer
Basic
Enterprise Profile

Basic Information

Subintro is a biotechnology company specializing in the development and provision of antiviral therapies for respiratory diseases caused by RNA viruses, including influenza, respiratory syncytial virus, rhinovirus, and SARS-CoV-2.
Subintro
United States of America
unclear
--
--
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Antibacterial/Antiviral Technology
Concept
Respiratory Department
Application Scenarios
Innovative Drugs